Galapagos NV (GLPG)
NASDAQ: GLPG · IEX Real-Time Price · USD
26.16
-0.59 (-2.21%)
At close: Jul 19, 2024, 4:00 PM
26.31
+0.15 (0.57%)
Pre-market: Jul 22, 2024, 4:02 AM EDT
Galapagos NV Employees
Galapagos NV had 1,123 employees as of December 31, 2023. The number of employees decreased by 215 or -16.07% compared to the previous year.
Employees
1,123
Change (1Y)
-215
Growth (1Y)
-16.07%
Revenue / Employee
n/a
Profits / Employee
n/a
Market Cap
1.72B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1,123 | -215 | -16.07% |
Dec 31, 2022 | 1,338 | 29 | 2.22% |
Dec 31, 2021 | 1,309 | 5 | 0.38% |
Dec 31, 2020 | 1,304 | 301 | 30.01% |
Dec 31, 2019 | 1,003 | 278 | 38.34% |
Dec 31, 2018 | 725 | 125 | 20.83% |
Dec 31, 2017 | 600 | 92 | 18.11% |
Dec 31, 2016 | 508 | 73 | 16.78% |
Dec 31, 2015 | 435 | 18 | 4.32% |
Dec 31, 2014 | 417 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Evotec SE | 4,952 |
Veracyte | 815 |
Supernus Pharmaceuticals | 652 |
Harmony Biosciences Holdings | 246 |
Kura Oncology | 142 |
Keros Therapeutics | 136 |
Neumora Therapeutics | 124 |
Ligand Pharmaceuticals | 58 |
GLPG News
- 5 weeks ago - Galapagos presents encouraging new data for CD19 CAR-T candidate GLPG5101 in non-Hodgkin lymphoma at EHA 2024 - GlobeNewsWire
- 7 weeks ago - Galapagos and Adaptimmune sign clinical collaboration agreement with an option to exclusively license Adaptimmune's TCR T-cell therapy candidate, uza-cel, in head & neck cancer and potential future solid tumor indications - GlobeNewsWire
- 7 weeks ago - Adaptimmune and Galapagos Sign Clinical Collaboration Agreement with an Option to Exclusively License Adaptimmune's TCR T-cell Therapy Candidate, uza-cel, in Head & Neck Cancer and Potential Future Solid Tumor Indications - Newsfile Corp
- 2 months ago - Galapagos creates new subscription right plans - GlobeNewsWire
- 2 months ago - Galapagos and Blood Centers of America announce strategic collaboration to accelerate Galapagos' decentralized CAR-T manufacturing network in the U.S. - GlobeNewsWire
- 2 months ago - Galapagos reports first quarter 2024 financial results - GlobeNewsWire
- 2 months ago - Galapagos' shareholders adopt all resolutions proposed by the Board of Directors at the Annual and Extraordinary Shareholders Meetings 2024 - GlobeNewsWire
- 3 months ago - Galapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024 - GlobeNewsWire